Pharma content supply chains have become overstretched by the rapid growth of, and demand for, digital marketing. As the number of channels and requests for content increases, so do the requirements for brand supervision, LMR approvals, production costs, and localisation efforts.
These internal structures and processes are now breaking down – creating backlogs and bottlenecks – and putting increasing pressure on people who are now struggling to cope.
The problem does not lie with any one department or function. It is systemic. The system simply wasn’t designed for the digital world. Increasing content production budgets – spending more to produce more – won’t solve the problem. What is needed is a supply chain that is designed for digital content. That system is content excellence.
Download our free whitepaper and learn: